Precision BioSciences Inc buy BMO Capital Markets
Start price
10.01.25
/
50%
€0.35
Target price
10.01.26
€33.15
Performance (%)
-
End price
11.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Precision BioSciences Inc | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% |
Comments by BMO_Capital_Markets for this prediction
In the thread Precision BioSciences Inc diskutieren
Precision BioSciences, Inc. (NASDAQ: DTIL) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat
In the thread Trading Precision BioSciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten